| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | CEO
1 company
Levin Jeremy M is an Executive Chairman at Ovid Therapeutics Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | OVID Ovid Therapeutics Inc. | CEO | Buy | 18,248 | $2.76 | $50,364.48 | +0.5% | -71.1% | -83.1% | |
| Aug 28, 2020 | OVID Ovid Therapeutics Inc. | CEO | Buy | 8,488 | $5.84 | $49,569.92 | +0.1% | - | - | |
| Oct 8, 2019 | OVID Ovid Therapeutics Inc. | CEO | Buy | 60,000 | $2.50 | $150,000.00 | +1.3% | - | - | |
| Feb 22, 2019 | OVID Ovid Therapeutics Inc. | CEO | Buy | 75,000 | $2.00 | $150,000.00 | +1.6% | - | - | |
| Aug 25, 2017 | OVID Ovid Therapeutics Inc. | CEO | Buy | 15,334 | $7.15 | $109,638.10 | +0.3% | - | - |